J. Goldman & Co’s Colgate-Palmolive CL Stock Holding History

J. Goldman & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-75,000	Closed	-$5.49M	–	313
2017 Q1	$5.49M	Buy	+75,000	New	+$5.25M	0.27%	116

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

J. Goldman & Co's CL Position: Q2 2017 in Review

J. Goldman & Co sold out of Colgate-Palmolive (CL) in Q2 2017, closing a stake of 1,701 shares — an estimated $124K sold.

J. Goldman & Co first reported a position in CL in Q3 2013 and held it in 2 quarters. The position peaked at $6.39M in Q3 2013. 1,370 funds tracked by Wall St. Rank hold CL as of Q2 2017.

J. Goldman & Co reported no remaining Colgate-Palmolive position as of Q2 2017 after selling out during the quarter.
J. Goldman & Co sold 1,701 Colgate-Palmolive shares in Q2 2017, an estimated $124K.
J. Goldman & Co first reported a position in Colgate-Palmolive in Q3 2013 and held it in 2 quarters.
J. Goldman & Co's Colgate-Palmolive position peaked at $6.39M in Q3 2013.
1,370 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2017.

Based on J. Goldman & Co's 13F filing for Q2 2017, filed 14 Aug 2017.